Melissa Angeline Durand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Melissa Angeline Durand has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Emily F. Conant
Department of Radiology, University of Pennsylvania, Philadelphia, PA
2 shared publications Regina J. Hooley
Department of Diagnostic Radiology and Biomedical Imaging, Yale University School of Medicine, 333 Cedar Street, PO Box 208042, New Haven, CT 06520-8042, USA
2 shared publications- Dave P. Miller
Genomic Health, Redwood City, CA
1 shared publication - Debra S. Copit1 shared publication
- Debra S. Copit
Albert Einstein Healthcare Network, Philadelphia, PA, USA
1 shared publication Donna M. Plecha
1 shared publication
Latest Publications
- 30 October 2024
- Published by Springer Nature
- p. 185-207
Architectural Distortions
- 1 January 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 306 (1) , 110-111
Equalizing the Performance of Radiologists and Physician Extenders in Screening Mammography
- 1 January 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 306 (1) , 110-111
Equalizing the Performance of Radiologists and Physician Extenders in Screening Mammography
- 1 January 2023
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 220 (1) , 62
Editorial Comment: With or Without Ultrasound Correlates, Multiple Architectural Distortions Still Warrant Biopsy
This Editorial Comment discusses the following AJR article: Pathologic Outcomes in Single Versus Multiple Areas of Architectural Distortion on Digital Breast Tomosynthesis.
- 1 January 2023
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 220 (1) , 62
Editorial Comment: With or Without Ultrasound Correlates, Multiple Architectural Distortions Still Warrant Biopsy
This Editorial Comment discusses the following AJR article: Pathologic Outcomes in Single Versus Multiple Areas of Architectural Distortion on Digital Breast Tomosynthesis.
- 1 October 2021
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 217 (4) , 854
Editorial Comment: Appropriate Management of Architectural Distortion Detected on Digital Breast Tomosynthesis
This Editorial Comment discusses the following AJR article: Tomosynthesis-Guided Vacuum-Assisted Breast Biopsy of Architectural Distortion Without a Sonographic Correlate: A Retrospective Review.
- 1 October 2021
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 217 (4) , 854
Editorial Comment: Appropriate Management of Architectural Distortion Detected on Digital Breast Tomosynthesis
This Editorial Comment discusses the following AJR article: Tomosynthesis-Guided Vacuum-Assisted Breast Biopsy of Architectural Distortion Without a Sonographic Correlate: A Retrospective Review.
- 1 February 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 298 (2) , 296-305
False-Negative Rates of Breast Cancer Screening with and without Digital Breast Tomosynthesis
Screening with digital breast tomosynthesis improves sensitivity and specificity, reveals more invasive cancers with fewer poor prognosis subtypes, and demonstrates a trend toward lower false-negat... Background Screening with digital breast tomosynthesis (DBT) improves breast cancer detection and recall rates compared with those obtained with digital mammography (DM); however, the impact of DBT...
- 1 February 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 298 (2) , 296-305
False-Negative Rates of Breast Cancer Screening with and without Digital Breast Tomosynthesis
Screening with digital breast tomosynthesis improves sensitivity and specificity, reveals more invasive cancers with fewer poor prognosis subtypes, and demonstrates a trend toward lower false-negat... Background Screening with digital breast tomosynthesis (DBT) improves breast cancer detection and recall rates compared with those obtained with digital mammography (DM); however, the impact of DBT...
- 1 June 2019
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 179 (6) , 853
Digital Breast Tomosynthesis for Women Older Than 70 Years
To the Editor In a Viewpoint article, Richman and Gross1 discussed the use of new breast cancer screening technologies in older women. Citing a study by Sharpe et al,2 they state “we are aware of only 1 study of digital breast tomosynthesis that has reported outcomes in women older than 70 years.”1 There have, however, been several studies on the use of digital breast tomosynthesis in older women. In the cited study,2 only 923 patients 70 years or older from 1 institution were screened with digital breast tomosynthesis. Thus, it is not surprising that significant differences in recall rates between digital breast tomosynthesis and digital mammography were not seen. Moreover, the study by Sharpe et al2 and cited by Richman and Gross1 has been criticized for errors in data analysis.3 For example, the authors excluded a cohort of about 9000 examinations read by lower-volume general radiologists from their analysis. However, cancer detection rate was calculated including this lower-volume cohort. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- 1 June 2019
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 179 (6) , 853
Digital Breast Tomosynthesis for Women Older Than 70 Years
To the Editor In a Viewpoint article, Richman and Gross1 discussed the use of new breast cancer screening technologies in older women. Citing a study by Sharpe et al,2 they state “we are aware of only 1 study of digital breast tomosynthesis that has reported outcomes in women older than 70 years.”1 There have, however, been several studies on the use of digital breast tomosynthesis in older women. In the cited study,2 only 923 patients 70 years or older from 1 institution were screened with digital breast tomosynthesis. Thus, it is not surprising that significant differences in recall rates between digital breast tomosynthesis and digital mammography were not seen. Moreover, the study by Sharpe et al2 and cited by Richman and Gross1 has been criticized for errors in data analysis.3 For example, the authors excluded a cohort of about 9000 examinations read by lower-volume general radiologists from their analysis. However, cancer detection rate was calculated including this lower-volume cohort. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- Open Access
- 4 April 2018
- Published by MDPI AG in Diagnostics
- Vol. 8 (2) , 22
Synthesized Mammography: Clinical Evidence, Appearance, and Implementation
Digital breast tomosynthesis (DBT) has improved conventional mammography by increasing cancer detection while reducing recall rates. However, these benefits come at the cost of increased radiation dose. Synthesized mammography (s2D) has been developed to provide the advantages of DBT with nearly half the radiation dose. Since its F.D.A. approval, multiple studies have evaluated the clinical performance of s2D. In clinical practice, s2D images are not identical to conventional 2D images and are designed for interpretation with DBT as a complement. This article reviews the present literature to assess whether s2D is a practical alternative to conventional 2D, addresses the differences in mammographic appearance of findings, and provides suggestions for implementation into clinical practice.
- 4 April 2018
- Published by MDPI AG in Diagnostics
- Vol. 8 (2) , 22
Open AccessSynthesized Mammography: Clinical Evidence, Appearance, and Implementation
Digital breast tomosynthesis (DBT) has improved conventional mammography by increasing cancer detection while reducing recall rates. However, these benefits come at the cost of increased radiation dose. Synthesized mammography (s2D) has been developed to provide the advantages of DBT with nearly half the radiation dose. Since its F.D.A. approval, multiple studies have evaluated the clinical performance of s2D. In clinical practice, s2D images are not identical to conventional 2D images and are designed for interpretation with DBT as a complement. This article reviews the present literature to assess whether s2D is a practical alternative to conventional 2D, addresses the differences in mammographic appearance of findings, and provides suggestions for implementation into clinical practice.
- 18 May 2017
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 164 (3) , 659-666
Effect of age on breast cancer screening using tomosynthesis in combination with digital mammography
Purpose To determine the effect of tomosynthesis imaging as a function of age for breast cancer screening. Methods Screening performance metrics from 13 institutions were examined for 12 months prior to introduction of tomosynthesis (period 1) and compared to those after introduction of tomosynthesis (period 2, range 3–22 months). Screening metrics for women ages 40–49, 50–59, 60–69, and 70+ , included rates per 1000 screens for recalls, biopsies, cancers, and invasive cancers detected. Results Performance parameters were compared for women screened with digital mammography alone (n = 278,908) and digital mammography + tomosynthesis (n = 173,414). Addition of tomosynthesis to digital mammography produced significant reductions in recall rates for all age groups and significant increases in cancer detection rates for women 40–69. Largest recall rate reduction with tomosynthesis was for women 40–49, decreasing from 137 (95% CI 117–156) to 115 (95% CI 95–135); difference, −22 (95% CI −26 to −18; P < .001). Simultaneous increase in invasive cancer detection rate for women 40–49 from 1.6 (95% CI 1.2–1.9) to 2.7 (95% CI 2.2–3.1) with tomosynthesis (difference, 1.1; 95% CI 0.6–1.6; P < .001) was observed. Conclusions Addition of tomosynthesis to digital mammography increased invasive cancer detection rates for women 40–69 and decreased recall rates for all age groups with largest performance gains seen in women 40–49. The similar performance seen with tomosynthesis screening for women in their 40s compared to digital mammography for women in their 50s argues strongly for commencement of mammography screening at age 40 using tomosynthesis.
- 18 May 2017
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 164 (3) , 659-666
Effect of age on breast cancer screening using tomosynthesis in combination with digital mammography
Purpose To determine the effect of tomosynthesis imaging as a function of age for breast cancer screening. Methods Screening performance metrics from 13 institutions were examined for 12 months prior to introduction of tomosynthesis (period 1) and compared to those after introduction of tomosynthesis (period 2, range 3–22 months). Screening metrics for women ages 40–49, 50–59, 60–69, and 70+ , included rates per 1000 screens for recalls, biopsies, cancers, and invasive cancers detected. Results Performance parameters were compared for women screened with digital mammography alone (n = 278,908) and digital mammography + tomosynthesis (n = 173,414). Addition of tomosynthesis to digital mammography produced significant reductions in recall rates for all age groups and significant increases in cancer detection rates for women 40–69. Largest recall rate reduction with tomosynthesis was for women 40–49, decreasing from 137 (95% CI 117–156) to 115 (95% CI 95–135); difference, −22 (95% CI −26 to −18; P < .001). Simultaneous increase in invasive cancer detection rate for women 40–49 from 1.6 (95% CI 1.2–1.9) to 2.7 (95% CI 2.2–3.1) with tomosynthesis (difference, 1.1; 95% CI 0.6–1.6; P < .001) was observed. Conclusions Addition of tomosynthesis to digital mammography increased invasive cancer detection rates for women 40–69 and decreased recall rates for all age groups with largest performance gains seen in women 40–49. The similar performance seen with tomosynthesis screening for women in their 40s compared to digital mammography for women in their 50s argues strongly for commencement of mammography screening at age 40 using tomosynthesis.
- 1 May 2017
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 55 (3) , 527-539
Implementation of Whole-Breast Screening Ultrasonography
- 1 May 2017
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 55 (3) , 527-539
Implementation of Whole-Breast Screening Ultrasonography
- 25 October 2016
- Published by Springer Nature in Current Breast Cancer Reports
- Vol. 8 (4) , 213-220
Can Tomosynthesis Replace 2D Mammography as a Future Breast Screening Tool?
- 25 October 2016
- Published by Springer Nature in Current Breast Cancer Reports
- Vol. 8 (4) , 213-220
Can Tomosynthesis Replace 2D Mammography as a Future Breast Screening Tool?